| Literature DB >> 33195838 |
Nausheen Joondan1, Marie Agnes Thessa Inassee1, Minu Gupta Bhowon1, Sabina Jhaumeer Laulloo1.
Abstract
Disulfide containing compounds are recognized for their wide range of bioEntities:
Keywords: Alkyl chain; Antibacterial; BSA; CMC; Disulfides; Molecular docking; Organic chemistry; Pharmaceutical chemistry; Theoretical chemistry
Year: 2020 PMID: 33195838 PMCID: PMC7644900 DOI: 10.1016/j.heliyon.2020.e05368
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Synthesis of compounds 1 to 5.
Figure 2Fluorescence spectrum of pyrene with increasing concentration of disulfide 3. The inset represents the Stern-Volmer plot.
CMC of compounds 1 to 5.
| Compound | Chain length | CMC (mM) |
|---|---|---|
| 1 | C8 | 0.163 |
| 2 | C10 | 0.130 |
| 3 | C12 | 0.108 |
| 4 | C14 | 0.075 |
| 5 | C16 | 0.054 |
Figure 3Graph of log CMC v/s Chain length (n).
Values for Stern-Volmer constant (Ksv), bimolecular quenching constant (Kq), binding constant (Ka) and number of binding site (n) for 1 to 5.
| Disulfide | Chain length | n | Ksv x 104 (M−1) | Kq x 1012 (M−1s−1) | Ka (M−1) |
|---|---|---|---|---|---|
| 1 | C8 | 0.76 | 7.45 | 7.45 | 5.47 × 103 |
| 2 | C10 | 1.23 | 2.26 | 2.26 | 2.25 × 105 |
| 3 | C12 | 1.22 | 3.16 | 3.16 | 5.88 × 108 |
| 4 | C14 | 1.27 | 25.8 | 25.8 | 6.89 × 106 |
| 5 | C16 | 0.74 | 1.40 | 1.40 | 1.02 × 103 |
Effect of temperature on the binding constant Ka and the thermodynamic parameters (ΔG, ΔH and ΔS) of the interaction of compounds 1 to 5 with BSA.
| Compound | Temperature (T) | 1/T/x 10−3 (K⁻1) | Ka/M−1 | ln Ka | ΔG (KJmol−1) | ΔH/(KJmol−1) | ΔS/(Jmol−1K−1) |
|---|---|---|---|---|---|---|---|
| 1 | 298 | 3.356 | 5.47 × 103 | 8.61 | -21.68 | -109.5 | -294.7 |
| 308 | 3.300 | 3.25 × 103 | 8.09 | -18.73 | |||
| 313 | 3.194 | 4.61 × 102 | 6.13 | -17.26 | |||
| 2 | 298 | 3.356 | 2.25 × 105 | 12.32 | -30.60 | -325.26 | -988.78 |
| 308 | 3.300 | 3.58 × 103 | 8.18 | -20.76 | |||
| 313 | 3.194 | 4.05 × 102 | 6.00 | -15.77 | |||
| 3 | 298 | 3.356 | 5.88 × 108 | 20.19 | -49.38 | -646.07 | -2002.29 |
| 308 | 3.300 | 4.62 × 104 | 10.74 | -29.36 | |||
| 313 | 3.194 | 2.79 × 103 | 7.93 | -19.35 | |||
| 4 | 298 | 3.356 | 6.90 × 106 | 13.45 | -32.08 | -84.02 | -174.29 |
| 308 | 3.300 | 1.14 × 105 | 11.64 | -30.34 | |||
| 313 | 3.194 | 1.07 × 105 | 11.58 | -29.47 | |||
| 5 | 298 | 3.356 | 1.02 × 103 | 6.93 | -16.18 | -97.23 | -271.98 |
| 308 | 3.300 | 5.70 × 101 | 4.04 | -13.46 | |||
| 313 | 3.194 | 2.93 × 102 | 5.48 | -12.10 |
ΔH: enthalpy change, ΔS: entropy change, ΔG: free energy.
Binding constants for competitive binding of compounds 1-5 in the presence of ibuprofen and warfarin.
| Compound | Site marker | Ka (M−1) |
|---|---|---|
| 1 | Blank | 5.06 × 103 |
| Warfarin | 4.95 × 103 | |
| Ibuprofen | 2.11 × 103 | |
| 2 | Blank | 4.29 × 105 |
| Warfarin | 1.57 × 104 | |
| Ibuprofen | 6.46 × 104 | |
| 3 | Blank | 1.06 × 109 |
| Warfarin | 1.03 × 107 | |
| Ibuprofen | 5.24 × 107 | |
| 4 | Blank | 3.83 × 106 |
| Warfarin | 3.42 × 105 | |
| Ibuprofen | 3.10 × 104 | |
| 5 | Blank | 1.79 × 105 |
| Warfarin | 3.83 × 103 | |
| Ibuprofen | 3.55 × 103 |
Binding free energies (ΔGbind) of the compounds in the Trp-213 binding site.
| Compound | ΔGbind (kJ mol−1) |
|---|---|
| 1 | -16.15 |
| 2 | -16.23 |
| 3 | -17.07 |
| 4 | -13.60 |
| 5 | +2.00 |
Figure 4Interaction diagrams for docking of 1–5 in the vicinity of Trp-213.
MIC values for compounds 1-5.
| MIC (mM) | |||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 5 | +ve control | |
| 12.5 | 5.40 | 2.50 | >10.0 | 0.0152 | |
| 3.12 | 2.53 | 10.0 | >12.5 | 0.0123 | |
| 21.4 | >25.3 | >36.5 | 56.3 | 0.686 | |
| 25.3 | 26.3 | 28.9 | 50.2 | 0.0107 | |
| >15.6 | 25.6 | >35.6 | >46.5 | 0.171 | |
+ve control: CTAB.
Figure 5HaCaT cells treated with (i) 10 mg/ml of disulfide 1, (ii) 10 mg/ml of disulfide 3, (iii) 20% DMSO (positive control) and (iv) 4% ethyl acetate (negative control).
% Cell viability in the presence of varying concentration of disulfides 1 to 4.
| Concentration/(mg/ml) | % Cell Viability | |||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| 20 | 18.4 | - | 100.0 | 100.0 |
| 10 | 23.0 | 63.7 | 100.0 | 100.0 |
| 5 | 62.6 | 100.0 | 100.0 | 100.0 |
| 2.5 | 82.9 | 100.0 | 92.1 | 100.0 |